MNKD MannKind Corp Total Asset Value of Company

MNKD (MannKind Corp.) - company brandmark

MannKind Corporation (MNKD) is developing an innovative inhalation drug delivery system, retaining customers through unique patented devices. The company strictly adheres to environmental standards regarding waste disposal. This daily price chart on the GURU.Markets platform shows that total assets reach 572.31. However, the business faces a liquidity shortage and weak market demand for its core developments, necessitating significant advertising expenditures.

MNKD (MannKind Corporation) Company Total Assets history from 07/04/2022 to 10/31/2026

Analytical breakdowns and data insights for company MannKind Corp. (MNKD)

- stock quotes and analyst forecast:
Share Price mannkindcorp.com|MNKD - Price Target Chart
- market capitalization data:
Market Valuation Afrezza|MNKD - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share MannKind|MNKD - Book Capitalization|Market Capitalization to Book Value Ratio mannkindcorp.com|MNKD - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio MannKind Corporation|MNKD - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Afrezza|MNKD - Company Aggregate Debts|Debts to Book Capitalization Afrezza|MNKD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings MannKind|Immediate Liquidity mannkindcorp.com
- net income and valuation multiples indicators:
MNKD - Net Income
Fundamental valuation:MannKind Corporation
Manufactured products of MannKind Corporation

Technosphere patent protection and stringent FDA oversight require significant resources from MannKind Corporation (MNKD), which is reflected in the balance sheet structure. This metric, reverse-calculated via ROA, combines equity and liabilities, demonstrating business development inertia and resilience to market shocks. By analyzing the current level of gross assets, an investor can assess the balance between the company's financial power and its capacity for operational flexibility.

Key competitors

Total Business Assets HLN|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aggregate Company Assets|Cumulative Company Assets ANI Pharmaceuticals Corp|AMPH (Amphastar Pharmaceuticals) - Company Total Assets|Company Total Assets pacira.com|Cumulative Company Assets SPRY (ARS Pharmaceuticals, Inc.)|TBPH (Theravance Biopharma Inc) - Aggregate Asset Value|Aggregate Company Assets Aquestive Pharma AQST|scPharmaceuticals, Inc. (SCPH) - Company Assets|TECX: Cumulative Company Assets|tonixpharma.com - Aggregate Business Assets|SXTC: Company Total Assets|Eupraxia Pharmaceuticals Inc. - Aggregate Asset Value|BHST (BioHarvest) - Company Total Assets|Company Assets Invizyne EXOZ|Aggregate Company Assets Oramed Pharmaceuticals (ORMP)|ENTX (enterabio.com) - Aggregate Asset Value|Aggregate Company Assets MindWalk Holdings Inc. HYFT|ABVC - Cumulative Company Assets|Cumberland Pharma - Company Total Assets|QNTM - Company Total Assets|FibroGen, Inc. (FGEN) - Aggregate Company Assets|Total Business Assets TELO|Aggregate Company Assets Rani Therapeutics Holdings|Total Business Assets SNYR (Synergy CHC Corporation)|Aggregate Company Assets Rallybio Corporation (RLYB)|Company Total Assets lexariabioscience.com (LEXX)|Company Total Assets PULM (Pulmatrix, Inc.)|Company Total Asset Base Pheton Holdings Limited (PTHL)|APM - Aggregate Company Assets|LYRA (Lyra Therapeutics Inc.) - Total Business Assets|IBO: Company Total Assets|Total Business Assets TNFA|Cumulative Company Assets YCBD|PRFX: Aggregate Asset Value|Company Total Assets CYTO|Cumulative Company Assets Lipella Pharmaceuticals Inc LIPO|Aggregate Company Assets Optinose OPTN|Pieris Pharma (PIRS) - Company Assets|PROC - Aggregate Company Assets|Aggregate Asset Value PTPI (petrospharma.com)|Qilian International Holding (QLI) - Aggregate Company Assets|Total Asset Value of Company SLRN (Acelyrin Inc.)|Aggregate Company Assets TFF Pharma